We are live on ! Find out more
CFO

CVA Family Office Portfolio holdings

AUM $1.1B
1-Year Est. Return 26.6%
This Fund
S&P 500
This Quarter Est. Return
-0.03%
1 Year Est. Return
+26.6%
3 Year Est. Return
+71.56%
5 Year Est. Return
+71.4%
10 Year Est. Return
AUM
$632M
AUM Growth
+$15.6M
Cap. Flow
+$22.2M
Cap. Flow %
3.51%
Top 10 Hldgs %
35.59%
Holding
1,357
New
91
Increased
542
Reduced
171
Closed
70

Sector Composition

Rank Sector Weight
1 Technology 8.77%
2 Financials 4.36%
3 Consumer Discretionary 2.73%
4 Healthcare 2.56%
5 Consumer Staples 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCI icon
1301
Donaldson
DCI
$11.4B
-15
Closed -$1.11K
DFIN icon
1302
Donnelley Financial Solutions
DFIN
$1.16B
-11
Closed -$724
DV icon
1303
DoubleVerify
DV
$2.03B
-28
Closed -$472
DYN icon
1304
Dyne Therapeutics
DYN
$4.9B
-12
Closed -$431
ENS icon
1305
EnerSys
ENS
$6.99B
-5
Closed -$510
EVH icon
1306
Evolent Health
EVH
$447M
-15
Closed -$424
FIVN icon
1307
FIVE9
FIVN
$2.54B
-15
Closed -$431
FL
1308
DELISTED
Foot Locker
FL
-21
Closed -$543
FOLD
1309
DELISTED
Amicus Therapeutics
FOLD
-43
Closed -$459
FRO icon
1310
Frontline
FRO
$8.85B
-58
Closed -$1.32K
GERN icon
1311
Geron
GERN
$949M
-129
Closed -$586
HII icon
1312
Huntington Ingalls Industries
HII
$12.8B
-10
Closed -$2.64K
PPLI
1313
People Inc
PPLI
$3.1B
-12
Closed -$538
BRSL
1314
Brightstar Lottery PLC
BRSL
$2.03B
-30
Closed -$639
INDV icon
1315
Indivior Pharmaceuticals
INDV
$4.58B
-204
Closed -$1.99K
IOVA icon
1316
Iovance Biotherapeutics
IOVA
$2.87B
-63
Closed -$592
KBH icon
1317
KB Home
KBH
$3.59B
-6
Closed -$514
KSS icon
1318
Kohl's
KSS
$2.19B
-27
Closed -$570
KYMR icon
1319
Kymera Therapeutics
KYMR
$8.94B
-12
Closed -$568
LEG icon
1320
Leggett & Platt
LEG
$1.31B
-3,182
Closed -$43.3K
LNW
1321
DELISTED
Light & Wonder
LNW
-5
Closed -$454
MDGL icon
1322
Madrigal Pharmaceuticals
MDGL
$11.8B
-2
Closed -$424
MPT
1323
Medical Properties Trust
MPT
$2.81B
-133
Closed -$778
MYGN icon
1324
Myriad Genetics
MYGN
$312M
-22
Closed -$603
NEU icon
1325
NewMarket
NEU
$8.18B
-1
Closed -$552

Similar funds

CVA Family Office's Q4 2024 Portfolio in Review

As of Q4 2024, CVA Family Office held 1,357 positions worth $632M, up 2.5% from $616M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CVA Family Office deployed $22.2M of net new capital in Q4 2024, opening 91 new positions and adding to 542 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 9,892 shares worth $749K.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, up from 8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $3.99M trimmed.

  • CVA Family Office's largest Q4 2024 buy was JPMorgan US Tech Leaders ETF: 9,892 shares worth $749K.
  • CVA Family Office added most to Invesco QQQ Trust in Q4 2024, an estimated $2.84M increase.
  • CVA Family Office's biggest Q4 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $3.99M.
  • CVA Family Office fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $101K.
  • CVA Family Office's ten largest holdings make up 36% of its $632M portfolio in Q4 2024.
  • CVA Family Office opened 91 new positions and closed 70 in Q4 2024.
  • CVA Family Office's portfolio value rose 2.5% quarter-over-quarter to $632M.

Based on CVA Family Office's 13F filing for Q4 2024, filed 7 Jan 2025.